SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Healthcare Global Enterprises gains on getting nod to invest in wholly owned subsidiaries

13 Nov 2025 Evaluate

Healthcare Global Enterprises is currently trading at Rs. 749.65, up by 1.00 points or 0.13% from its previous closing of Rs. 748.65 on the BSE.

The scrip opened at Rs. 740.00 and has touched a high and low of Rs. 748.70 and Rs. 726.60 respectively. So far 18850 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 804.30 on 29-Oct-2025 and a 52 week low of Rs. 455.75 on 13-Nov-2024.

Last one week high and low of the scrip stood at Rs. 769.15 and Rs. 726.60 respectively. The current market cap of the company is Rs. 10434.01 crore.

The promoters holding in the company stood at 63.78%, while Institutions and Non-Institutions held 21.95% and 14.27% respectively.

Healthcare Global Enterprises has received approval to invest up to Rs 110 crore in HCG Kolkata Cancer Care LLP, Rs 15 crore in HCG Oncology Hospitals LLP, and Rs 25 crore in HCG NCHRI Oncology LLP, wholly owned subsidiaries of the company. The investments in the wholly owned subsidiaries are primarily for repayment of dues, working capital and for general corporate purposes. The investment will be completed on or before March 31, 2026.

The Board of Directors of the company has, at their meeting held on November 12, 2025, has approved same.

Healthcare Global Enterprises (HCG) is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann’ brand.

HealthcareGlobal Share Price

566.55 -0.25 (-0.04%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×